Replies to post #6 on Bohai Pharmaceutical (fka BOPH)

[ErnieBilco]

Started watching this about 2 weeks ago.

[2morrowsGains]

The kicker is in the pro forma (acquisition) numbers hidden in this filing...
http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001144204%2D11%2D045138%2Etxt&FilePath=%5C2011%5C08%5C10%5C&CoName=BOHAI+PHARMACEUTICALS+GROUP%2C+INC%2E&FormType=8%2DK&RcvdDate=8%2F10%2F2011&pdf=
Bohai Pharmaceuticals could easily come in w/ adjusted (after backing out changes in fair value of derivative liabilities) pro forma EPS (inc acquisition) of approx $0.80+ for FY2011. Current stock price is $0.82.
PE = 1.
10k is due out in a few weeks.

BTW, BOPH is also looking to uplist...


http://ir.stockpr.com/bohaipharma/presentations/view/193/noble-financial-capital-markets-seventh-annual-equity-conference